Clareo Health | A Study of the Long-term Safety of ABT-089 for Subjects With Mild-to-moderate Alzheimer's Disease Who Participated in the M06-876 Study
Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Abbott
Age
55–90
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
The subject was randomized into Study M06-876 and completed the study.
The subject must remain on the same dose of AChEI that was used during the M06-876 study.
The subject is in general good health, as judged by the investigator
You may not be if
The subject is currently, or plans to participate in another experimental study during the course of this trial.
The subject anticipates a move outside the geographic area of the investigative site or is planning extended travel inconsistent with the recommended visit intervals.
